A	0	1	O
key	2	5	O
role	6	10	O
for	11	14	O
the	15	18	O
integrin	19	27	B-Gene_or_gene_product
alpha2beta1	28	39	I-Gene_or_gene_product
in	40	42	O
experimental	43	55	O
and	56	59	O
developmental	60	73	O
angiogenesis	74	86	O
.	86	87	O

The	89	92	O
alpha2beta1	93	104	B-Gene_or_gene_product
integrin	105	113	I-Gene_or_gene_product
receptor	114	122	I-Gene_or_gene_product
plays	123	128	O
a	129	130	O
key	131	134	O
role	135	139	O
in	140	142	O
angiogenesis	143	155	O
.	155	156	O

Here	157	161	O
we	162	164	O
investigated	165	177	O
the	178	181	O
effects	182	189	O
of	190	192	O
small	193	198	O
molecule	199	207	O
inhibitors	208	218	O
(	219	220	O
SMIs	220	224	O
)	224	225	O
designed	226	234	O
to	235	237	O
disrupt	238	245	O
integrin	246	254	B-Gene_or_gene_product
alpha2	255	261	I-Gene_or_gene_product
I	262	263	O
or	264	266	O
beta1	267	272	B-Gene_or_gene_product
I	273	274	O
-	274	275	O
like	275	279	O
domain	280	286	O
function	287	295	O
on	296	298	O
angiogenesis	299	311	O
.	311	312	O

In	313	315	O
unchallenged	316	328	O
endothelial	329	340	B-Cell
cells	341	346	I-Cell
,	346	347	O
fibrillar	348	357	B-Gene_or_gene_product
collagen	358	366	I-Gene_or_gene_product
induced	367	374	O
robust	375	381	O
capillary	382	391	B-Tissue
morphogenesis	392	405	O
.	405	406	O

In	407	409	O
contrast	410	418	O
,	418	419	O
tube	420	424	B-Tissue
formation	425	434	O
was	435	438	O
significantly	439	452	O
reduced	453	460	O
by	461	463	O
SMI496	464	470	B-Drug_or_compound
,	470	471	O
a	472	473	O
beta1	474	479	B-Gene_or_gene_product
I	480	481	O
-	481	482	O
like	482	486	O
domain	487	493	O
inhibitor	494	503	O
and	504	507	O
by	508	510	O
function	511	519	O
-	519	520	O
blocking	520	528	O
anti	529	533	B-Drug_or_compound
-	533	534	I-Drug_or_compound
alpha2beta1	534	545	I-Drug_or_compound
but	546	549	O
not	550	553	O
-	554	555	B-Drug_or_compound
alpha1beta1	555	566	I-Drug_or_compound
antibodies	567	577	I-Drug_or_compound
.	577	578	O

Endothelial	579	590	B-Cell
cells	591	596	I-Cell
bound	597	602	O
fluorescein	603	614	O
-	614	615	O
labeled	615	622	O
collagen	623	631	B-Gene_or_gene_product
I	632	633	I-Gene_or_gene_product
fibrils	634	641	I-Gene_or_gene_product
,	641	642	O
an	643	645	O
interaction	646	657	O
specifically	658	670	O
inhibited	671	680	O
by	681	683	O
SMI496	684	690	B-Drug_or_compound
.	690	691	O

Moreover	692	700	O
,	700	701	O
SMI496	702	708	B-Drug_or_compound
caused	709	715	O
cell	716	720	B-Cell
retraction	721	731	O
and	732	735	O
cytoskeletal	736	748	O
collapse	749	757	O
of	758	760	O
endothelial	761	772	B-Cell
cells	773	778	I-Cell
as	779	781	O
well	782	786	O
as	787	789	O
delayed	790	797	O
endothelial	798	809	B-Cell
cell	810	814	I-Cell
wound	815	820	O
healing	821	828	O
.	828	829	O

SMI	830	833	O
activities	834	844	O
were	845	849	O
examined	850	858	O
in	859	861	O
vivo	862	866	O
by	867	869	O
supplementing	870	883	O
the	884	887	O
growth	888	894	O
medium	895	901	O
of	902	904	O
zebrafish	905	914	B-Organism
embryos	915	922	B-Developing_anatomical_structure
expressing	923	933	O
green	934	939	B-Gene_or_gene_product
fluorescent	940	951	I-Gene_or_gene_product
protein	952	959	I-Gene_or_gene_product
under	960	965	O
the	966	969	O
control	970	977	O
of	978	980	O
the	981	984	O
vascular	985	993	B-Gene_or_gene_product
endothelial	994	1005	I-Gene_or_gene_product
growth	1006	1012	I-Gene_or_gene_product
factor	1013	1019	I-Gene_or_gene_product
receptor	1020	1028	I-Gene_or_gene_product
-	1028	1029	I-Gene_or_gene_product
2	1029	1030	I-Gene_or_gene_product
promoter	1031	1039	B-DNA_domain_or_region
.	1039	1040	O

SMI496	1041	1047	B-Drug_or_compound
,	1047	1048	O
but	1049	1052	O
not	1053	1056	O
a	1057	1058	O
control	1059	1066	O
compound	1067	1075	O
,	1075	1076	O
interfered	1077	1087	O
with	1088	1092	O
angiogenesis	1093	1105	O
in	1106	1108	O
vivo	1109	1113	O
by	1114	1116	O
reversibly	1117	1127	O
inhibiting	1128	1138	O
sprouting	1139	1148	O
from	1149	1153	O
the	1154	1157	O
axial	1158	1163	B-Multi-tissue_structure
vessels	1164	1171	I-Multi-tissue_structure
.	1171	1172	O

We	1173	1175	O
further	1176	1183	O
characterized	1184	1197	O
zebrafish	1198	1207	B-Organism
alpha2	1208	1214	B-Gene_or_gene_product
integrin	1215	1223	I-Gene_or_gene_product
and	1224	1227	O
discovered	1228	1238	O
that	1239	1243	O
this	1244	1248	O
integrin	1249	1257	B-Gene_or_gene_product
is	1258	1260	O
highly	1261	1267	O
conserved	1268	1277	O
,	1277	1278	O
especially	1279	1289	O
the	1290	1293	O
I	1294	1295	O
domain	1296	1302	O
.	1302	1303	O

Notably	1304	1311	O
,	1311	1312	O
a	1313	1314	O
similar	1315	1322	O
vascular	1323	1331	O
phenotype	1332	1341	O
was	1342	1345	O
induced	1346	1353	O
by	1354	1356	O
morpholino	1357	1367	O
-	1367	1368	O
mediated	1368	1376	O
knockdown	1377	1386	O
of	1387	1389	O
the	1390	1393	O
integrin	1394	1402	B-Gene_or_gene_product
alpha2	1403	1409	I-Gene_or_gene_product
subunit	1410	1417	O
.	1417	1418	O

By	1419	1421	O
live	1422	1426	O
videomicroscopy	1427	1442	O
,	1442	1443	O
we	1444	1446	O
confirmed	1447	1456	O
that	1457	1461	O
the	1462	1465	O
vessels	1466	1473	B-Multi-tissue_structure
were	1474	1478	O
largely	1479	1486	O
nonfunctional	1487	1500	O
in	1501	1503	O
the	1504	1507	O
absence	1508	1515	O
of	1516	1518	O
alpha2beta1	1519	1530	B-Gene_or_gene_product
integrin	1531	1539	I-Gene_or_gene_product
.	1539	1540	O

Collectively	1541	1553	O
,	1553	1554	O
our	1555	1558	O
results	1559	1566	O
provide	1567	1574	O
strong	1575	1581	O
biochemical	1582	1593	O
and	1594	1597	O
genetic	1598	1605	O
evidence	1606	1614	O
of	1615	1617	O
a	1618	1619	O
central	1620	1627	O
role	1628	1632	O
for	1633	1636	O
alpha2beta1	1637	1648	B-Gene_or_gene_product
integrin	1649	1657	I-Gene_or_gene_product
in	1658	1660	O
experimental	1661	1673	O
and	1674	1677	O
developmental	1678	1691	O
angiogenesis	1692	1704	O
.	1704	1705	O

